PSN 034
PSN 034, licence 80002197: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Veevance Inc.
- NPN or DIN-HM
- 80002197
- Status
- Inactive licence
- Licence date
- 2 October 2006
- Revision date
- 6 July 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Hyssopus officinalis L.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Hyssopus officinalis Source : Feuille(s) Extract : Solide Extraction ratio : 4:1 Dry plant equivalent : 1000 mg | 250.0 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium végétal, Cellulose, microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Utilisée traditionellement pour stimuler la digestion (aromate). Utilisée traditionellement pour aider à l'évacuation des gaz intestinaux (carminatif). Utilisée traditionellement comme tonique pour fortifier et soulager les muqueses des voies respiratoires et des voies gastro-intestinales. Utilisée traditionellement comme expectorant pour soulager la toux et autres affections des poumons. Utilisée traditionellement pour fortifier le système respiratoire (pectoral). Utilisée traditionellement pour rédiure la fièvre. Utilisée traditionellement pour induire la sudation (diaphorétique)
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un practicien de soins de santé si les symtômes sont graves ou persistent plus de 2 jours. Consulter un practicien de soins de santé si la toux s'aggrave, persiste pendent plus de 7 jours ou est accompagnée d'une forte fiévre.
- Contre-indications
Ne pas utiliser en cas de gorssess ou d'allaitement.
Source
Official Health Canada record, licence 80002197
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.